# Minocycline in Clinically Isolated Syndromes (CIS)

> **NCT00666887** · PHASE3 · COMPLETED · sponsor: **Dr. Luanne Metz** · enrollment: 142 (actual)

## Conditions studied

- Clinically Isolated Syndromes
- Early Single Relapse of Multiple Sclerosis

## Interventions

- **DRUG:** Minocycline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00666887
- **Lead sponsor:** Dr. Luanne Metz
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2014-12
- **Final completion:** 2015-07
- **Target enrollment:** 142 (ACTUAL)
- **Last updated:** 2017-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00666887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00666887, "Minocycline in Clinically Isolated Syndromes (CIS)". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00666887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*